Drugs News and Research

RSS

CETSA helps scientists determine effectiveness of drugs in the body

The search for new drugs, including those for cancer, is set to speed up thanks to a new research technique invented by scientists at the Nanyang Technological University.

20 Jul 2013

IVAN study: Lucentis and Avastin effective in treating wet AMD

An anti-cancer drug has been proven to be equally as effective in treating the most common cause of blindness in older adults as a more expensive drug specifically formulated for this purpose.

20 Jul 2013

Researchers identify mechanism behind pediatric solid tumors

Most of the time, it takes decades of accumulating genetic errors for a tumor to develop. While this explains the general occurrence of cancer in adults, it leaves a gap in understanding of the cause of pediatric tumors.

20 Jul 2013

Researchers demonstrate that 2-drug combination can eliminate cancer

New research conducted by Harvard scientists is laying out a roadmap to one of the holy grails of modern medicine - a cure for cancer.

20 Jul 2013

Community health faces new subpoena into Medicare admissions practices

Community Health has received a subpoena for two executives to testify in an investigation into its Medicare admissions. The hospital operator also reports its income fell 57 percent on weak patient volume and debt.

20 Jul 2013

Ketamine anesthesia drug can cause learning and memory disorders in children

Recent studies have found that anesthesia drugs have neurotoxicity on the developing neurons, causing learning and memory disorders and behavioral abnormalities. Ketamine is commonly used in pediatric anesthesia.

20 Jul 2013

UCSF researchers find a way to knock down cancers caused by tumor-driving protein

UC San Francisco researchers have found a way to knock down cancers caused by a tumor-driving protein called -myc,- paving the way for patients with myc-driven cancers to enroll in clinical trials for experimental treatments.

20 Jul 2013

First Edition: July 19, 2013

Today's headlines include coverage of President Barack Obama's Thursday speech pitching the positives of the health law.

19 Jul 2013

EHRA, AEPC release joint consensus statement on treatment of paediatric arrhythmias

A joint consensus statement on the treatment of paediatric arrhythmias has been released by the European Heart Rhythm Association of the European Society of Cardiology and the Association for European Paediatric and Congenital Cardiology.

19 Jul 2013

Tianyin Pharmaceutical provides further updates on Gingko Mihuan Oral Liquid

Tianyin Pharmaceutical Co., Inc., a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional Chinese medicine, branded generics and active pharmaceutical ingredients today provided further updates on the business development of its flagship product: Gingko Mihuan Oral Liquid with the SFDA approval number: H20013079.

19 Jul 2013

Scientists take important step toward pharmacologic development of treatment for fatal brain disorders

A team of researchers from Case Western Reserve University School of Medicine have identified a mechanism that can prevent the normal prion protein from changing its molecular shape into the abnormal form responsible for neurodegenerative diseases. This finding, published in the July 18 issue of Cell Reports, offers new hope in the battle against a foe that until now has always proved fatal.

19 Jul 2013

UK Markey Cancer Center receives National Cancer Institute designation

The University of Kentucky Markey Cancer Center was joined by national, state and local leaders last Friday to celebrate its designation as a National Cancer Institute cancer center.

19 Jul 2013

UCSF researchers find way to knock down cancers caused by myc protein

UC San Francisco researchers have found a way to knock down cancers caused by a tumor-driving protein called "myc," paving the way for patients with myc-driven cancers to enroll in clinical trials for experimental treatments.

19 Jul 2013

Study shows link between reclassification of cannabis, hospital admissions for cannabis psychosis

Researchers from the University of York have demonstrated that the change in cannabis declassification in 2009 has coincided with a significant increase in hospital admissions for cannabis psychosis - rather than the decrease it was intended to produce.

19 Jul 2013

Nanotechnology drug kills brain-tumor cells and retards growth of tumor blood vessels

An experimental drug in early development for aggressive brain tumors can cross the blood-brain tumor barrier and kill tumor cells and block the growth of tumor blood vessels, according to a study led by researchers at the Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James).

19 Jul 2013

Kansas researchers defeat persistent bacteria known for causing infections in hospitals

Kansas State University researchers are defeating persistent bacteria known for causing infections in hospitals.

19 Jul 2013

FDA grants orphan drug designation to ARMAGEN's AGT-182 for treatment of Hunter syndrome

ARMAGEN announced today that the U.S. Food and Drug Administration has granted orphan drug designation to its lead product AGT-182 for the treatment of mucopolysaccharidosis type II (also known as Hunter syndrome or MPS II).

19 Jul 2013

HemoShear announces milestone in development of predictive drug safety systems

HemoShear, LLC, a leading developer of human-relevant systems for drug development and discovery, today announced an important milestone in the development of systems that predict safety of new drugs and chemicals.

19 Jul 2013

Ecological framework provides better understanding of health-related quality of life in Parkinson's patients

Bronfenbrenner's ecological systems theory emphasizes the development of a series of nested environment systems with which an individual interacts. These systems interact with the individual, and also affect the development of the individual.

19 Jul 2013

Researchers develop new drug delivery technique for diabetes treatment

Researchers have developed a drug delivery technique for diabetes treatment in which a sponge-like material surrounds an insulin core. The sponge expands and contracts in response to blood sugar levels to release insulin as needed. The technique could also be used for targeted drug delivery to cancer cells.

19 Jul 2013

Drugs News and Research

CETSA helps scientists determine effectiveness of drugs in the body

IVAN study: Lucentis and Avastin effective in treating wet AMD

Researchers identify mechanism behind pediatric solid tumors

Researchers demonstrate that 2-drug combination can eliminate cancer

Community health faces new subpoena into Medicare admissions practices

Ketamine anesthesia drug can cause learning and memory disorders in children

UCSF researchers find a way to knock down cancers caused by tumor-driving protein

First Edition: July 19, 2013

EHRA, AEPC release joint consensus statement on treatment of paediatric arrhythmias

Tianyin Pharmaceutical provides further updates on Gingko Mihuan Oral Liquid

Scientists take important step toward pharmacologic development of treatment for fatal brain disorders

UK Markey Cancer Center receives National Cancer Institute designation

UCSF researchers find way to knock down cancers caused by myc protein

Study shows link between reclassification of cannabis, hospital admissions for cannabis psychosis

Nanotechnology drug kills brain-tumor cells and retards growth of tumor blood vessels

Kansas researchers defeat persistent bacteria known for causing infections in hospitals

FDA grants orphan drug designation to ARMAGEN's AGT-182 for treatment of Hunter syndrome

HemoShear announces milestone in development of predictive drug safety systems

Ecological framework provides better understanding of health-related quality of life in Parkinson's patients

Researchers develop new drug delivery technique for diabetes treatment

Industry Focus eBook - Cell biology (5th edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News